Therapies that prevent cardiovascular events, kidney disease, liver disease, sleep apnea, or even neurodegeneration could unlock massive new markets
Moreover, NHANES data indicate that less than 9% of pregnant women meet the AI for choline (106)
More than half of participants achieved 10% weight loss, over one-third achieved 15%, and nearly one-fifth reached 20%
What the last two plus years have shown GLP-1s and craving, addiction, and compulsive behaviors One of the most significant developments since 2023 is growing evidence that GLP-1 medications may reduce cravings beyond food
Changes in Blood Flow: Wegovy may influence blood flow by altering blood vessel tone and function, contributing to clot formation, especially in individuals with underlying vascular conditions
Patients taking or considering semaglutide alongside thyroid medication should consult their healthcare provider in several specific circumstances